The company’s strategy for global markets is different from the India market and is not solely based on leveraging ...

Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses.

The pharmaceutical company is evaluating all options to increase its presence in therapy areas, including in-licensing ...

Novartis introduces a financing scheme with Pine Labs for its cholesterol-lowering drug, Sybrava (inclisiran), in India, ...

Theravance Biopharma and Mylan settle a patent dispute with Eugia Pharma over Yupelri, delaying generic entry until 2039.

Shares of Mankind Pharma Ltd were trading in the red today even as the pharma firm said its board has approved the closure of the issue for the qualified institutions placement (QIP) of equity ...

The Nifty Pharma index jumped 1% to 21,585.35. The index increased 1.08% for the two consecutive trading sessions.

ONGC, Indigo, Colgate, Oil India, IndusInd Bank, NTPC Green Energy, Power Finance Corporation, and Rail Vikas Nigam among 133 companies to release their earnings report today.

On Thursday, JPMorgan analysts revised the price target for Mankind Pharma Ltd (MANKIND:IN), reducing it to INR2,900 from the previous INR3,150. Despite this adjustment, the firm retains an ...

Mankind Pharma on Wednesday reported a 10% year-on-year (YoY) decrease in net profit to Rs 429 crore in Q4 FY24, attributed to one-time costs related to the integration of BSV. Revenue from ...

(Reuters) -Indian drugmaker Mankind Pharma reported a fourth-quarter profit that beat analysts' estimates on Wednesday, driven by strong domestic demand for its drugs to treat long-term illnesses. The ...